Company: BNBX
Filing Date: 2025-11-04
Form Type: 424B5
Source: 0001104659-25-105958
Chunk: 45

Company: BNB PLUS CORP.
Filing Date: 2025-11-04
Form: 424B5
Chunk 45
---
 unless such
exhibits are specifically incorporated by reference into such documents) by writing to us at Corporate Secretary, Applied DNA Sciences, Inc.,
50 Health Sciences Drive, Stony Brook, New York 11790 or visiting our website at . Information contained on
our website is not incorporated by reference into this prospectus supplement, and it should not be considered to be part of this prospectus
supplement.

Any statement contained in a document incorporated
or deemed to be incorporated by reference in this prospectus shall be deemed to be modified or superseded for the purposes of this prospectus
to the extent that a statement contained herein, any prospectus supplement or in any other subsequently filed document which also is or
deemed to be incorporated by reference herein modifies or supersedes that statement. Any statement so modified or superseded shall not
be deemed, except as so modified or superseded, to constitute a part of this prospectus.

| S-28 |

<div align='center'>PROSPECTUS

$75,000,000

APPLIED DNA SCIENCES, INC.

Common Stock

Preferred Stock

Debt Securities

Warrants

Rights

Units</div>

We may offer and sell, from time to time in one or more offerings,
up to $75,000,000 of our common stock, preferred stock, debt securities, warrants and rights, or any combination of these securities,
and/or units consisting of one or more of these securities. We may also offer common stock or preferred stock upon conversion of debt
securities and common stock upon conversion of preferred stock. All of the securities listed above may be sold separately or as units
with other securities.

This prospectus describes some of the general terms that may apply
to these securities. When we decide to sell a particular class or series of securities, we will provide specific terms of the offered
securities in one or more prospectus supplements. We may also authorize one or more free writing prospectuses to be provided to you in
connection with these offerings.

The prospectus supplement, and any documents incorporated by reference,
may also add, update or change information contained in or incorporated by reference into this prospectus. However, no prospectus supplement
shall offer a security that is not registered and described in this prospectus at the time of its effectiveness. You should read this
prospectus and any prospectus supplement, as well as the documents incorporated by reference or deemed to be incorporated by reference
into this prospectus, and any free writing prospectus